| Mrs Brittnee Cleveland, MS CCC-SLP | |
|
3869 Sw Hall Blvd, Beaverton, OR 97005-2049 | |
| (503) 946-5375 | |
| (503) 626-0663 |
| Full Name | Mrs Brittnee Cleveland |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3869 Sw Hall Blvd, Beaverton, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326581778 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 015236 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Brittnee Cleveland, MS CCC-SLP 3869 Sw Hall Blvd, Beaverton, OR 97005-2049 Ph: (503) 946-5375 | Mrs Brittnee Cleveland, MS CCC-SLP 3869 Sw Hall Blvd, Beaverton, OR 97005-2049 Ph: (503) 946-5375 |
News Archive
Exoskeletons - wearable devices used by workers on assembly lines or in warehouses to alleviate stress on their lower backs - may compete with valuable resources in the brain while people work, canceling out the physical benefits of wearing them, a new study suggests.
Kinetic Concepts, Inc. today announced the completion of its acquisition by an affiliate of a consortium comprised of investment funds advised by Apax Partners and controlled affiliates of Canada Pension Plan Investment Board and the Public Sector Pension Investment Board pursuant to a merger agreement dated July 12, 2011.
Until now, attention-deficit/hyperactivity disorder (ADHD) was related to alterations in the brain affecting attention and cognitive processes. Researchers at Universitat Aut-noma de Barcelona and the Vall d'Hebron University Hospital for the first time have discovered anomalies in the brain's reward system related to the neural circuits of motivation and gratification.
Genzyme Corporation today announced three-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate. Sustained or further improvements were observed across all endpoints, including bone disease, at the three-year timepoint.
› Verified 8 days ago
Ryan Joseph Depauw, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1815 Nw 169th Pl Ste 3070, Beaverton, OR 97006 Phone: 971-249-2653 Fax: 503-747-4373 | |
Stephanie K. Crawford, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1500 Nw Bethany Blvd, Beaverton, OR 97006 Phone: 503-346-0640 Fax: 503-346-8040 | |
Kate England, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17185 Sw Watercrest Ct, Beaverton, OR 97006 Phone: 503-645-3898 | |
Mrs. Naomi J Beale, MS SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14645 Sw Farmington Rd, Beaverton, OR 97007 Phone: 503-643-8626 | |
Sarah Lynn Kuhrts, MS, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4900 Sw Griffith Drive, Suite 157, Beaverton, OR 97005 Phone: 503-517-8555 Fax: 503-517-8556 | |
Rachel Prevost, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13200 Sw Butner Rd, Beaverton, OR 97005 Phone: 702-305-7842 | |
Mrs. Tatiana Virginia Ledoux, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8625 Sw Cascade Ave Ste 320, Beaverton, OR 97008 Phone: 877-755-8940 |